Back
Structure Therapeutics Vs. Amgen Industry Stock Comparison
Sell
40
GPCR
Structure Therapeutics
Last Price:
39.29
Seasonality Move:
-35.87%
Sell
47
AMGN
Amgen
Last Price:
319.23
Seasonality Move:
10.36%
Sell
40
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy, Sell or Hold?
- The current Structure Therapeutics [GPCR] share price is $39.74. The Score for GPCR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- GPCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Amgen (AMGN)
is a Sell
Is Amgen a Buy, Sell or Hold?
- The current Amgen [AMGN] share price is $316.98. The Score for AMGN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- AMGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GPCR Stock Price Chart
What is Structure Therapeutics's stock price today?
-
The Structure Therapeutics share price today is $39.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.
AMGN Stock Price Chart
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 51.34 | Buy |
| Chaikin Money Flow: | -625102 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.61 - 41.77) | Buy |
| Bollinger Bands (100): | (36.09 - 43.17) | Buy |
AMGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.85 | Sell |
| Relative Strength Index (14 RSI): | 44.8 | Sell |
| Chaikin Money Flow: | -326637 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (316.3 - 322.8) | Sell |
| Bollinger Bands (100): | (313.97 - 332.09) | Sell |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.92 | Buy |
| 20-day SMA: | 38.87 | Buy |
| 50-day SMA: | 39.6 | Buy |
| 200-day SMA: | 40.28 | Sell |
| 8-day EMA: | 39.45 | Buy |
| 20-day EMA: | 39.31 | Buy |
| 50-day EMA: | 39.42 | Buy |
| 200-day EMA: | 39.73 | Buy |
AMGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 317.26 | Sell |
| 20-day SMA: | 319.46 | Sell |
| 50-day SMA: | 324.29 | Sell |
| 200-day SMA: | 306.56 | Buy |
| 8-day EMA: | 317.92 | Sell |
| 20-day EMA: | 319.39 | Sell |
| 50-day EMA: | 321.66 | Sell |
| 200-day EMA: | 307.67 | Buy |
Structure Therapeutics Earnings Growth & GPCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.07 per share.
Amgen Earnings Growth & AMGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $1.08 per share.
Structure Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amgen Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||